Patent ID: 9616055
Date: 2017-04-11
CPC Classifications: A61K,A61P

Claim:
1. An oral controlled release dosage form comprising a formulation comprising: methylphenidate at about 5 to about 30 wt % relative to the total weight of the formulation; sucrose acetate isobutyrate (SAIB) at about 30 to about 45 wt % relative to the total weight of the formulation; a rheology modifier at about 2 to about 15 wt % relative to the total weight of the formulation; a network former at about 2 to about 10 wt % relative to the total weight of the formulation; a solvent at about 15 to about 40 wt % relative to the total weight of the formulation; a viscosity enhancing agent at about 0.1 to about 2 wt % relative to the total weight of the formulation; and a saturated polyglycolized glyceride at about 0.01 to about 5 wt % relative to the total weight of the formulation.